User profiles for Sam Afkhami
 | Sam AfkhamiMcMaster University Verified email at mcmaster.ca Cited by 2813 |
[HTML][HTML] Immunological considerations for COVID-19 vaccine strategies
The coronavirus disease 2019 (COVID-19) pandemic caused by severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) is the most formidable challenge to humanity in a …
syndrome coronavirus 2 (SARS-CoV-2) is the most formidable challenge to humanity in a …
[PDF][PDF] Respiratory mucosal delivery of next-generation COVID-19 vaccine provides robust protection against both ancestral and variant strains of SARS-CoV-2
The emerging SARS-CoV-2 variants of concern (VOCs) threaten the effectiveness of current
COVID-19 vaccines administered intramuscularly and designed to only target the spike …
COVID-19 vaccines administered intramuscularly and designed to only target the spike …
[PDF][PDF] Induction of autonomous memory alveolar macrophages requires T cell help and is critical to trained immunity
Innate immune memory is an emerging area of research. However, innate immune memory
at major mucosal sites remains poorly understood. Here, we show that respiratory viral …
at major mucosal sites remains poorly understood. Here, we show that respiratory viral …
[HTML][HTML] Parenteral BCG vaccine induces lung-resident memory macrophages and trained immunity via the gut–lung axis
Aside from centrally induced trained immunity in the bone marrow (BM) and peripheral
blood by parenteral vaccination or infection, evidence indicates that mucosal-resident innate …
blood by parenteral vaccination or infection, evidence indicates that mucosal-resident innate …
[HTML][HTML] Aerosol delivery, but not intramuscular injection, of adenovirus-vectored tuberculosis vaccine induces respiratory-mucosal immunity in humans
M Jeyanathan, DK Fritz, S Afkhami, E Aguirre… - JCI insight, 2022 - ncbi.nlm.nih.gov
Background Adenovirus-vectored (Ad-vectored) vaccines are typically administered via im
injection to humans and are incapable of inducing respiratory mucosal immunity. However, …
injection to humans and are incapable of inducing respiratory mucosal immunity. However, …
[HTML][HTML] COVID‐19: Current knowledge in clinical features, immunological responses, and vaccine development
The COVID‐19 pandemic has unfolded to be the most challenging global health crisis in a
century. In 11 months since its first emergence, according to WHO, the causative infectious …
century. In 11 months since its first emergence, according to WHO, the causative infectious …
[HTML][HTML] Methods and clinical development of adenovirus-vectored vaccines against mucosal pathogens
Adenoviruses represent the most widely used viral-vectored platform for vaccine design,
showing a great potential in the fight against intracellular infectious diseases to which either …
showing a great potential in the fight against intracellular infectious diseases to which either …
Adenoviral-vectored next-generation respiratory mucosal vaccines against COVID-19
The world is in need of next-generation COVID-19 vaccines. Although first-generation injectable
COVID-19 vaccines continue to be critical tools in controlling the current global health …
COVID-19 vaccines continue to be critical tools in controlling the current global health …
Innate immune memory of tissue-resident macrophages and trained innate immunity: Re-vamping vaccine concept and strategies
In the past few years, our understanding of immunological memory has evolved remarkably
due to a growing body of new knowledge in innate immune memory and immunity. …
due to a growing body of new knowledge in innate immune memory and immunity. …
New tuberculosis vaccine strategies: taking aim at un-natural immunity
Despite some major progress made in developing tuberculosis (TB) vaccine strategies, with
a dozen novel vaccines currently in the clinical pipeline, the world is still missing an effective …
a dozen novel vaccines currently in the clinical pipeline, the world is still missing an effective …